首页 > 最新文献

Minimally Invasive Therapy & Allied Technologies最新文献

英文 中文
3-Fr steerable microcatheter system via the upper limb artery in RADPLAT for right maxillary cancer. 在 RADPLAT 中通过上肢动脉的 3-Fr 可转向微导管系统治疗右上颌骨癌。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-02-01 Epub Date: 2024-05-28 DOI: 10.1080/13645706.2024.2359718
Masao Takahashi, Ken Nakazawa, Yoko Usami, Yuki Natsuyama, Yuichi Tsukamoto, Jun Suzuki, Shiho Asami, Hitoshi Inoue, Satoko Matsumura, Mitsuhiko Nakahira, Tetsu Saito, Shingo Kato, Yoshitaka Okada, Hiroyuki Tajima, Eito Kozawa, Yasutaka Baba

Background: To evaluate the efficacy of a catheter system using a 3-Fr sheath with a steerable microcatheter through right upper limb artery access for superselective intra-arterial cisplatin infusion and concomitant radiotherapy (RADPLAT) to treat right maxillary sinus squamous cell carcinoma (MS-SCC).

Material and methods: We retrospectively studied 46 sessions in eight patients treated between November 2020 and February 2023 using the catheter system briefly described below. A 3-Fr sheath was inserted into the distal radial, conventional radial, or brachial arteries. A coaxial catheter system with a 2.9-Fr steerable microcatheter and a 1.9-Fr microcatheter was advanced into the brachiocephalic artery. The right common carotid artery was selected by bending the tip of the steerable microcatheter. Coil embolization and intra-arterial cisplatin infusion after selecting each external carotid artery branch were achieved using this catheter system.

Results: Cisplatin infusion and coil embolization were successful in all sessions. Arterial occlusion at the sheath insertion sites was found in 29.4% (5/17) of the distal radial arteries and 33.3% (3/9) of the conventional radial arteries. No other major complications were observed during the procedure.

Conclusion: Using a 3-Fr catheter system with a steerable microcatheter through right upper limb artery access is a feasible method for RADPLAT in treating right MS-SCC.

背景:材料与方法:我们回顾性研究了2020年11月至2023年2月期间使用导管系统治疗8例患者的46次疗程:我们回顾性研究了2020年11月至2023年2月期间使用导管系统对8名患者进行的46次治疗,简要介绍如下。在桡动脉远端、常规桡动脉或肱动脉中插入一个 3 英尺长的鞘。将带有 2.9-Fr 可转向微导管和 1.9-Fr 微导管的同轴导管系统推进肱脑动脉。通过弯曲可转向微导管的尖端,选择了右侧颈总动脉。在选择每个颈外动脉分支后,使用该导管系统实现了线圈栓塞和顺铂动脉内输注:结果:所有疗程的顺铂输注和线圈栓塞均获得成功。29.4%(5/17)的桡动脉远端和33.3%(3/9)的常规桡动脉鞘插入部位出现动脉闭塞。手术期间未发现其他重大并发症:结论:通过右上肢动脉入路使用带有可转向微导管的 3-Fr 导管系统是治疗右侧 MS-SCC 的一种可行的 RADPLAT 方法。
{"title":"3-Fr steerable microcatheter system via the upper limb artery in RADPLAT for right maxillary cancer.","authors":"Masao Takahashi, Ken Nakazawa, Yoko Usami, Yuki Natsuyama, Yuichi Tsukamoto, Jun Suzuki, Shiho Asami, Hitoshi Inoue, Satoko Matsumura, Mitsuhiko Nakahira, Tetsu Saito, Shingo Kato, Yoshitaka Okada, Hiroyuki Tajima, Eito Kozawa, Yasutaka Baba","doi":"10.1080/13645706.2024.2359718","DOIUrl":"10.1080/13645706.2024.2359718","url":null,"abstract":"<p><strong>Background: </strong>To evaluate the efficacy of a catheter system using a 3-Fr sheath with a steerable microcatheter through right upper limb artery access for superselective intra-arterial cisplatin infusion and concomitant radiotherapy (RADPLAT) to treat right maxillary sinus squamous cell carcinoma (MS-SCC).</p><p><strong>Material and methods: </strong>We retrospectively studied 46 sessions in eight patients treated between November 2020 and February 2023 using the catheter system briefly described below. A 3-Fr sheath was inserted into the distal radial, conventional radial, or brachial arteries. A coaxial catheter system with a 2.9-Fr steerable microcatheter and a 1.9-Fr microcatheter was advanced into the brachiocephalic artery. The right common carotid artery was selected by bending the tip of the steerable microcatheter. Coil embolization and intra-arterial cisplatin infusion after selecting each external carotid artery branch were achieved using this catheter system.</p><p><strong>Results: </strong>Cisplatin infusion and coil embolization were successful in all sessions. Arterial occlusion at the sheath insertion sites was found in 29.4% (5/17) of the distal radial arteries and 33.3% (3/9) of the conventional radial arteries. No other major complications were observed during the procedure.</p><p><strong>Conclusion: </strong>Using a 3-Fr catheter system with a steerable microcatheter through right upper limb artery access is a feasible method for RADPLAT in treating right MS-SCC.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"53-60"},"PeriodicalIF":1.7,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141157151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
10-year experience with single-site laparoscopic-assisted Soave operation for Hirschsprung disease.
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-01-26 DOI: 10.1080/13645706.2025.2454966
Yun-Jin Wang, Yi-Fan Fang, Hua-Jun Cai, Liu Chen, Chao-Ming Zhou, Guo-Xian Guan

Background: The aim of this study was to investigate the clinical outcomes after a transumbilical single-site laparoscopic-assisted Soave operation (TSLSO) for Hirschsprung disease (HD) in children, with a 10-year follow‑up results assessment.

Methods: We retrospectively analyzed the clinical data of 165 children with HD from January 2013 to January 2023. The operation method was a TSLSO. The operation time, intraoperative bleeding, postoperative abdominal drainage time, postoperative hospitalization time, and postoperative complications were analyzed.

Results: All 165 cases were successfully completed using the TSLSO. The median operative time was 160 (120-210) minutes, and the median volume of bleeding was 9 mL (3-15 mL). The median length of the resected intestine was 25 cm (20-32 cm), and the median postoperative peritoneal drainage time was 4.2 days (3-6 days). Postoperative defecation function generally recovered well, there was no recurrence of constipation. There were three cases of anal stenosis, 12 cases of perianal dermatitis, two cases of adhesive intestinal obstruction, 14 cases of soiling, and 18 cases of enterocolitis.

Conclusion: The TSLSO is a safe and feasible surgical method for the treatment of HD in children. It has the advantages of little bleeding, a good cosmetic effect, and fast postoperative recovery. However, it does require skilled laparoscopic technique by the surgeon.

{"title":"10-year experience with single-site laparoscopic-assisted Soave operation for Hirschsprung disease.","authors":"Yun-Jin Wang, Yi-Fan Fang, Hua-Jun Cai, Liu Chen, Chao-Ming Zhou, Guo-Xian Guan","doi":"10.1080/13645706.2025.2454966","DOIUrl":"https://doi.org/10.1080/13645706.2025.2454966","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to investigate the clinical outcomes after a transumbilical single-site laparoscopic-assisted Soave operation (TSLSO) for Hirschsprung disease (HD) in children, with a 10-year follow‑up results assessment.</p><p><strong>Methods: </strong>We retrospectively analyzed the clinical data of 165 children with HD from January 2013 to January 2023. The operation method was a TSLSO. The operation time, intraoperative bleeding, postoperative abdominal drainage time, postoperative hospitalization time, and postoperative complications were analyzed.</p><p><strong>Results: </strong>All 165 cases were successfully completed using the TSLSO. The median operative time was 160 (120-210) minutes, and the median volume of bleeding was 9 mL (3-15 mL). The median length of the resected intestine was 25 cm (20-32 cm), and the median postoperative peritoneal drainage time was 4.2 days (3-6 days). Postoperative defecation function generally recovered well, there was no recurrence of constipation. There were three cases of anal stenosis, 12 cases of perianal dermatitis, two cases of adhesive intestinal obstruction, 14 cases of soiling, and 18 cases of enterocolitis.</p><p><strong>Conclusion: </strong>The TSLSO is a safe and feasible surgical method for the treatment of HD in children. It has the advantages of little bleeding, a good cosmetic effect, and fast postoperative recovery. However, it does require skilled laparoscopic technique by the surgeon.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"1-7"},"PeriodicalIF":1.7,"publicationDate":"2025-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143047137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endovascular robotics: technical advances and future directions. 血管内机器人技术:技术进展和未来方向。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-01-21 DOI: 10.1080/13645706.2025.2454237
Matteo Pescio, Dennis Kundrat, Giulio Dagnino

Endovascular interventions excel in treating cardiovascular diseases in a minimally invasive manner, showing improved outcomes over open techniques. However, challenges related to precise navigation - still relying on 2D fluoroscopy - persist. This review examines the role of robotics, highlighting commercial and research platforms, while exploring emerging trends like MRI compatibility, enhanced navigation, and autonomy. MRI-compatible systems offer radiation-free 3D imaging. Human-robot interaction evolves with task-specific interfaces, while autonomy ranges from partial to full, aiding clinical operators. Challenges include complexity and cost, emphasizing compatibility and navigation advancements. Integrating MRI-compatible robots, refining human-robot interaction, and enhancing autonomy promise advancements in endovascular surgery, fueled by AI and innovative imaging.

血管内介入在以微创方式治疗心血管疾病方面表现出色,显示出比开放技术更好的结果。然而,与精确导航相关的挑战——仍然依赖于二维透视——仍然存在。这篇综述探讨了机器人的作用,突出了商业和研究平台,同时探索了MRI兼容性、增强导航和自主性等新兴趋势。核磁共振兼容系统提供无辐射的3D成像。人机交互随着任务特定界面的发展而发展,而自主范围从部分到完全,为临床操作员提供帮助。挑战包括复杂性和成本,强调兼容性和导航的进步。在人工智能和创新成像的推动下,集成与mri兼容的机器人,改进人机交互,增强自主性,有望在血管内手术方面取得进展。
{"title":"Endovascular robotics: technical advances and future directions.","authors":"Matteo Pescio, Dennis Kundrat, Giulio Dagnino","doi":"10.1080/13645706.2025.2454237","DOIUrl":"https://doi.org/10.1080/13645706.2025.2454237","url":null,"abstract":"<p><p>Endovascular interventions excel in treating cardiovascular diseases in a minimally invasive manner, showing improved outcomes over open techniques. However, challenges related to precise navigation - still relying on 2D fluoroscopy - persist. This review examines the role of robotics, highlighting commercial and research platforms, while exploring emerging trends like MRI compatibility, enhanced navigation, and autonomy. MRI-compatible systems offer radiation-free 3D imaging. Human-robot interaction evolves with task-specific interfaces, while autonomy ranges from partial to full, aiding clinical operators. Challenges include complexity and cost, emphasizing compatibility and navigation advancements. Integrating MRI-compatible robots, refining human-robot interaction, and enhancing autonomy promise advancements in endovascular surgery, fueled by AI and innovative imaging.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"1-14"},"PeriodicalIF":1.7,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143008277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of endoscopic resection for gastric gastrointestinal stromal tumors: a retrospective cohort study. 内镜下胃肠道间质瘤切除术的安全性和有效性:一项回顾性队列研究。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2025-01-10 DOI: 10.1080/13645706.2024.2449266
Xiaodan Zhao, Yadong Feng, Mingyue Li, Ye Zhu, Xiajiao Tang, Ruihua Shi

Background: The aim of this study was to verify the safety and efficacy of endoscopic resection (ER) for gastric gastrointestinal stromal tumors (GISTs).

Methods: Among a consecutive series of resections for gastric GISTs performed in a single center, the outcomes of patients who had ER were compared to standard surgical resection (SR).

Results: In the cohort, 329 consecutive primary localized gastric GISTs patients (n, ER/SR = 251/78) were enrolled. Patients receiving ER were revealed to have preferable post-treatment outcomes, prolonged overall survival (OS) and disease-free survival (DFS). Tumor diameter, the only independent risk factor for a complicated post-operative course, was utilized for propensity score matching (PSM). In the PSM cohort, patients receiving ER and SR with similar tumor size (4.0 [2.7-4.5] cm) shared similar aggressiveness in terms of stomach layers of tumor origination and invasion, and modified National Institutes of Health (mNIH) risk criteria. Shorter operative time, fewer economic costs, and shorter post-operative stay were still observed in the ER group (ER vs. SR: 80 [49-120] vs. 120 [98-160] minutes, p < 0.001; 44 [38-51] vs. 60 [49-84] thousand Renminbi [kRMB], p < 0.001; 7.0 [6.0-8.0] vs. 8.5 [6.0-12] days, p = 0.018, respectively). No significant difference in OS and DFS was demonstrated in the PSM cohort.

Conclusions: ER is safe and effective, thus a feasible treatment option for indicated gastric GISTs patients with the advantage of faster recovery and lower economic costs.

背景:本研究的目的是验证内镜下切除(ER)治疗胃肠道间质瘤(gist)的安全性和有效性。方法:在单一中心进行的连续一系列胃胃肠道间质瘤切除术中,将ER患者的结果与标准手术切除(SR)进行比较。结果:在队列中,329例连续的原发性局部胃gist患者(n, ER/SR = 251/78)被纳入。接受ER治疗的患者具有较好的治疗后预后,延长了总生存期(OS)和无病生存期(DFS)。肿瘤直径是术后复杂病程的唯一独立危险因素,用于倾向评分匹配(PSM)。在PSM队列中,接受ER和SR治疗的肿瘤大小相似(4.0 [2.7-4.5]cm)的患者在肿瘤起源和侵袭的胃层方面具有相似的侵袭性,并修改了美国国立卫生研究院(mNIH)的风险标准。ER组手术时间更短,经济成本更低,术后住院时间更短(ER与SR: 80 [49-120] vs. 120 [98-160] min, p p p = 0.018)。在PSM队列中,OS和DFS没有显着差异。结论:内窥镜治疗安全有效,具有恢复快、经济成本低的优势,是适应期胃间质瘤患者可行的治疗选择。
{"title":"Safety and efficacy of endoscopic resection for gastric gastrointestinal stromal tumors: a retrospective cohort study.","authors":"Xiaodan Zhao, Yadong Feng, Mingyue Li, Ye Zhu, Xiajiao Tang, Ruihua Shi","doi":"10.1080/13645706.2024.2449266","DOIUrl":"https://doi.org/10.1080/13645706.2024.2449266","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to verify the safety and efficacy of endoscopic resection (ER) for gastric gastrointestinal stromal tumors (GISTs).</p><p><strong>Methods: </strong>Among a consecutive series of resections for gastric GISTs performed in a single center, the outcomes of patients who had ER were compared to standard surgical resection (SR).</p><p><strong>Results: </strong>In the cohort, 329 consecutive primary localized gastric GISTs patients (<i>n</i>, ER/SR = 251/78) were enrolled. Patients receiving ER were revealed to have preferable post-treatment outcomes, prolonged overall survival (OS) and disease-free survival (DFS). Tumor diameter, the only independent risk factor for a complicated post-operative course, was utilized for propensity score matching (PSM). In the PSM cohort, patients receiving ER and SR with similar tumor size (4.0 [2.7-4.5] cm) shared similar aggressiveness in terms of stomach layers of tumor origination and invasion, and modified National Institutes of Health (mNIH) risk criteria. Shorter operative time, fewer economic costs, and shorter post-operative stay were still observed in the ER group (ER vs. SR: 80 [49-120] vs. 120 [98-160] minutes, <i>p</i> < 0.001; 44 [38-51] vs. 60 [49-84] thousand Renminbi [kRMB], <i>p</i> < 0.001; 7.0 [6.0-8.0] vs. 8.5 [6.0-12] days, <i>p</i> = 0.018, respectively). No significant difference in OS and DFS was demonstrated in the PSM cohort.</p><p><strong>Conclusions: </strong>ER is safe and effective, thus a feasible treatment option for indicated gastric GISTs patients with the advantage of faster recovery and lower economic costs.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"1-11"},"PeriodicalIF":1.7,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142951256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of liposomal as compared to standard bupivacaine for intercostal nerve blocks in patients undergoing minimally invasive thoracic surgery: a systematic review and meta-analysis. 与标准布比卡因相比,脂质体对微创胸外科患者肋间神经阻滞的疗效:一项系统评价和荟萃分析。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2024-12-24 DOI: 10.1080/13645706.2024.2440910
Ruliang Chen, Zhibo Wang

Background: This review aimed to provide evidence on the efficacy of liposomal bupivacaine as compared to standard bupivacaine for intercostal nerve blocks (ICB) in patients undergoing minimally invasive thoracic surgery.

Methods: Randomized controlled trials (RCTs) and comparative observational studies published on the databases of PubMed, CENTRAL, Web of Science, and Embase up to June 20, 2024, were included. Total opioid consumption in morphine equivalents, pain scores, and length of hospital stay (LOS) were compared.

Results: Two RCTs and eight observational studies were included. Eight hundred and four patients received liposomal bupivacaine while 631 patients received standard bupivacaine in the included studies. The meta-analysis showed that the use of liposomal bupivacaine for ICB did not reduce opioid consumption as compared to standard bupivacaine at 24 h, 48 h, and for the total duration of hospitalization. Pain scores were also not significantly different between the two groups at 24 h and 48 h. Meta-analysis showed that there was no difference in the LOS between intervention and control groups. Subgroup analysis based on study design also generated similar results.

Conclusions: Mostly low-quality evidence shows that liposomal bupivacaine does not offer additional benefits over standard bupivacaine when used for ICB in patients undergoing minimally invasive thoracic surgery.

背景:本综述旨在为布比卡因脂质体与标准布比卡因在微创胸外科患者肋间神经阻滞(ICB)中的疗效提供证据。方法:纳入截至2024年6月20日在PubMed、CENTRAL、Web of Science和Embase数据库中发表的随机对照试验(RCTs)和比较观察性研究。比较吗啡当量、疼痛评分和住院时间(LOS)的阿片类药物总消耗量。结果:纳入2项随机对照试验和8项观察性研究。在纳入的研究中,840例患者接受脂质体布比卡因治疗,631例患者接受标准布比卡因治疗。荟萃分析显示,与标准布比卡因相比,在24小时、48小时和总住院时间内,使用布比卡因脂质体治疗ICB并没有减少阿片类药物的消耗。两组在24 h和48 h的疼痛评分也无显著差异。meta分析显示,干预组与对照组的LOS无差异。基于研究设计的亚组分析也产生了类似的结果。结论:大多数低质量的证据表明,在微创胸外科患者中使用脂质体布比卡因治疗ICB时,与标准布比卡因相比,布比卡因没有额外的益处。
{"title":"Efficacy of liposomal as compared to standard bupivacaine for intercostal nerve blocks in patients undergoing minimally invasive thoracic surgery: a systematic review and meta-analysis.","authors":"Ruliang Chen, Zhibo Wang","doi":"10.1080/13645706.2024.2440910","DOIUrl":"https://doi.org/10.1080/13645706.2024.2440910","url":null,"abstract":"<p><strong>Background: </strong>This review aimed to provide evidence on the efficacy of liposomal bupivacaine as compared to standard bupivacaine for intercostal nerve blocks (ICB) in patients undergoing minimally invasive thoracic surgery.</p><p><strong>Methods: </strong>Randomized controlled trials (RCTs) and comparative observational studies published on the databases of PubMed, CENTRAL, Web of Science, and Embase up to June 20, 2024, were included. Total opioid consumption in morphine equivalents, pain scores, and length of hospital stay (LOS) were compared.</p><p><strong>Results: </strong>Two RCTs and eight observational studies were included. Eight hundred and four patients received liposomal bupivacaine while 631 patients received standard bupivacaine in the included studies. The meta-analysis showed that the use of liposomal bupivacaine for ICB did not reduce opioid consumption as compared to standard bupivacaine at 24 h, 48 h, and for the total duration of hospitalization. Pain scores were also not significantly different between the two groups at 24 h and 48 h. Meta-analysis showed that there was no difference in the LOS between intervention and control groups. Subgroup analysis based on study design also generated similar results.</p><p><strong>Conclusions: </strong>Mostly low-quality evidence shows that liposomal bupivacaine does not offer additional benefits over standard bupivacaine when used for ICB in patients undergoing minimally invasive thoracic surgery.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"1-11"},"PeriodicalIF":1.7,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142882442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction. 修正。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2024-12-18 DOI: 10.1080/13645706.2024.2443726
{"title":"Correction.","authors":"","doi":"10.1080/13645706.2024.2443726","DOIUrl":"https://doi.org/10.1080/13645706.2024.2443726","url":null,"abstract":"","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"1"},"PeriodicalIF":1.7,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142854798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy and safety of precutting-endoscopic mucosal resection for colorectal tumors: a systematic review and meta-analysis. 内镜粘膜切除术治疗结直肠肿瘤的有效性和安全性:系统综述和荟萃分析。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2024-12-12 DOI: 10.1080/13645706.2024.2440403
Yi Chen, Zhengjie Wu

Background: Several modified endoscopic mucosal resection (EMR) techniques have been reported for colorectal tumors. Precutting-EMR (PEMR) is a modification wherein a circumferential mucosal incision is made around a lesion to facilitate en bloc resection. This review compared the efficacy and safety of PEMR with conventional EMR for colorectal lesions.

Methods: PubMed, Embase, Scopus, and Web of Science were searched for comparative studies available before February 15, 2024. This systematic review and meta-analysis were recorded in PROSPERO, identified as CRD42024509143.

Results: Two hundred and eight studies underwent screening of which seven studies were found eligible. We found no significant difference in en bloc resection rates but complete resection rates were significantly better with PEMR. The duration of the procedure was significantly longer with PEMR as compared to EMR. There was no difference in the risk of delayed bleeding and recurrence between the two groups but the risk of perforation was significantly increased with PEMR.

Conclusions: The use of PEMR for colorectal lesions can improve complete resection rates, albeit at the cost of increased duration of the procedure and higher perforation rates compared to conventional EMR. PEMR may also have a tendency of better en bloc resection rates which needs to be confirmed by further studies.

背景:有报道称,有几种改良的内镜粘膜切除术(EMR)可用于结直肠肿瘤。预切-EMR(PEMR)是一种改良技术,即在病变周围做一个环形粘膜切口,以便于进行全切。本综述比较了PEMR与传统EMR治疗结直肠病变的有效性和安全性:方法:检索了 PubMed、Embase、Scopus 和 Web of Science 上 2024 年 2 月 15 日之前的对比研究。本系统综述和荟萃分析已录入 PROSPERO,编号为 CRD42024509143:结果:共筛选出 28 项研究,其中 7 项符合条件。我们发现全块切除率没有明显差异,但完全切除率明显优于 PEMR。与EMR相比,PEMR的手术时间明显更长。两组患者发生延迟出血和复发的风险没有差异,但PEMR患者发生穿孔的风险明显增加:结论:与传统的EMR相比,使用PEMR治疗结直肠病变可提高完全切除率,但代价是手术时间延长,穿孔率升高。PEMR也有可能提高全切率,这需要进一步研究证实。
{"title":"The efficacy and safety of precutting-endoscopic mucosal resection for colorectal tumors: a systematic review and meta-analysis.","authors":"Yi Chen, Zhengjie Wu","doi":"10.1080/13645706.2024.2440403","DOIUrl":"https://doi.org/10.1080/13645706.2024.2440403","url":null,"abstract":"<p><strong>Background: </strong>Several modified endoscopic mucosal resection (EMR) techniques have been reported for colorectal tumors. Precutting-EMR (PEMR) is a modification wherein a circumferential mucosal incision is made around a lesion to facilitate en bloc resection. This review compared the efficacy and safety of PEMR with conventional EMR for colorectal lesions.</p><p><strong>Methods: </strong>PubMed, Embase, Scopus, and Web of Science were searched for comparative studies available before February 15, 2024. This systematic review and meta-analysis were recorded in PROSPERO, identified as CRD42024509143.</p><p><strong>Results: </strong>Two hundred and eight studies underwent screening of which seven studies were found eligible. We found no significant difference in en bloc resection rates but complete resection rates were significantly better with PEMR. The duration of the procedure was significantly longer with PEMR as compared to EMR. There was no difference in the risk of delayed bleeding and recurrence between the two groups but the risk of perforation was significantly increased with PEMR.</p><p><strong>Conclusions: </strong>The use of PEMR for colorectal lesions can improve complete resection rates, albeit at the cost of increased duration of the procedure and higher perforation rates compared to conventional EMR. PEMR may also have a tendency of better en bloc resection rates which needs to be confirmed by further studies.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"1-10"},"PeriodicalIF":1.7,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142818611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-time indocyanine green fluorescence imaging and navigation for cone unit laparoscopic hepatic resection of intrahepatic duct stone: a case series study. 圆锥单元腹腔镜肝切除肝内导管结石的实时吲哚菁绿荧光成像和导航:一项病例系列研究。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2024-12-01 Epub Date: 2024-10-05 DOI: 10.1080/13645706.2024.2410369
Jianjie Hao, Donghui Cheng, Jipeng Jiang, Bangyou Zuo, Yu Zhang

Background: Intrahepatic bile duct stones, although common and benign, require varying therapeutic strategies due to their recurrent nature. Inadequate management can escalate to liver cirrhosis or cholangiocarcinoma. A surgical method merging indocyanine green fluorescence imaging (ICG-FI) with liver cone unit resection is optimal, ensuring complete lesion removal and healthy liver tissue conservation.

Method: A retrospective descriptive study was conducted on 15 patients with intrahepatic bile duct stones who were admitted to Sichuan Provincial People's Hospital from January 2021 to December 2023. All patients underwent laparoscopic anatomical liver resection guided by ICG-FI.

Results: Among the 15 patients included in the study, ten were male and five were female, with an average age of 52 years. All patients were free from underlying medical conditions. Intraoperatively, ICG-FI was good, with clear boundaries, and all patients successfully underwent surgery without any conversions to open surgery. The mean operative time was 236 ± 56 min, and the estimated blood loss was 320 ± 75 ml. Patients had a postoperative hospital stay of 5.5 ± 1.5 days. No severe complications occurred.

Conclusions: Real-time ICG-FI with anatomical liver resection is a safe and effective approach for managing intrahepatic bile duct stones.

背景:肝内胆管结石虽然是常见的良性结石,但由于其复发性,需要采取不同的治疗策略。如果处理不当,可能会发展为肝硬化或胆管癌。将吲哚菁绿荧光成像(ICG-FI)与肝锥体单元切除术相结合的手术方法是最佳选择,既能确保彻底清除病灶,又能保留健康的肝组织:方法:对四川省人民医院2021年1月至2023年12月收治的15例肝内胆管结石患者进行回顾性描述性研究。所有患者均在ICG-FI的引导下接受了腹腔镜肝脏解剖切除术:15例患者中,男性10例,女性5例,平均年龄52岁。所有患者均无基础疾病。术中,ICG-FI效果良好,边界清晰,所有患者均成功接受了手术,无一例转为开放手术。平均手术时间为 236 ± 56 分钟,估计失血量为 320 ± 75 毫升。患者术后住院时间为(5.5±1.5)天。无严重并发症发生:实时 ICG-FI 结合解剖性肝切除术是治疗肝内胆管结石的一种安全有效的方法。
{"title":"Real-time indocyanine green fluorescence imaging and navigation for cone unit laparoscopic hepatic resection of intrahepatic duct stone: a case series study.","authors":"Jianjie Hao, Donghui Cheng, Jipeng Jiang, Bangyou Zuo, Yu Zhang","doi":"10.1080/13645706.2024.2410369","DOIUrl":"10.1080/13645706.2024.2410369","url":null,"abstract":"<p><strong>Background: </strong>Intrahepatic bile duct stones, although common and benign, require varying therapeutic strategies due to their recurrent nature. Inadequate management can escalate to liver cirrhosis or cholangiocarcinoma. A surgical method merging indocyanine green fluorescence imaging (ICG-FI) with liver cone unit resection is optimal, ensuring complete lesion removal and healthy liver tissue conservation.</p><p><strong>Method: </strong>A retrospective descriptive study was conducted on 15 patients with intrahepatic bile duct stones who were admitted to Sichuan Provincial People's Hospital from January 2021 to December 2023. All patients underwent laparoscopic anatomical liver resection guided by ICG-FI.</p><p><strong>Results: </strong>Among the 15 patients included in the study, ten were male and five were female, with an average age of 52 years. All patients were free from underlying medical conditions. Intraoperatively, ICG-FI was good, with clear boundaries, and all patients successfully underwent surgery without any conversions to open surgery. The mean operative time was 236 ± 56 min, and the estimated blood loss was 320 ± 75 ml. Patients had a postoperative hospital stay of 5.5 ± 1.5 days. No severe complications occurred.</p><p><strong>Conclusions: </strong>Real-time ICG-FI with anatomical liver resection is a safe and effective approach for managing intrahepatic bile duct stones.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"351-357"},"PeriodicalIF":1.7,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142378081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complete mesocolic excision (CME) impacts survival only for Stage III right-sided colon cancer: a systematic review and meta-analysis. 完全结肠系膜切除术 (CME) 仅影响 III 期右侧结肠癌患者的生存率:系统综述和荟萃分析。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2024-12-01 Epub Date: 2024-09-25 DOI: 10.1080/13645706.2024.2405544
Kengo Hayashi, Roberto Passera, Chiara Meroni, Rebecca Dallorto, Chiara Marafante, Carlo Alberto Ammirati, Alberto Arezzo

Introduction: Complete mesocolic excision (CME) is widely adopted for its assumed superior oncological outcome. However, it's unclear if all right-sided colon cancer patients benefit from CME. The aim of this systematic review is to investigate whether CME contributes to postoperative outcomes and to determine the surgical indications for CME.

Material and methods: We searched eligible articles about CME versus non-CME procedures for right-sided colon cancer in the OVID Medline, Embase, and Cochrane CENTRAL databases, and a meta-analysis was conducted.

Results: Twenty-two articles and seven abstracts involving 8088 patients were included in this study. Among them, 3803 underwent CME and 4285 non-CME procedures. The analysis showed that CME was favoured for three-year disease-free survival (DFS) and overall survival (OS), for local, systemic, and total recurrence, and for hospital stay durations. However, increased vascular injury and longer surgery time were observed in CME. Regarding the three-year OS, the superiority of CME was observed only in Stage III. Additionally, no significant differences were observed between CME and non-CME groups regarding overall complications, 30-day readmission rates, reoperation, or postoperative mortality rates.

Conclusions: CME for right-sided colon cancer should be considered, particularly in Stage III patients, to contribute to improved oncological outcomes. However, careful attention must be paid to the increased risk of vascular injury.

导言:结肠系膜完全切除术(CME)因其假定的优越肿瘤治疗效果而被广泛采用。然而,尚不清楚是否所有右侧结肠癌患者都能从 CME 中获益。本系统性综述旨在研究 CME 是否有助于术后效果,并确定 CME 的手术适应症:我们在 OVID Medline、Embase 和 Cochrane CENTRAL 数据库中检索了符合条件的关于右侧结肠癌 CME 与非 CME 手术的文章,并进行了荟萃分析:本研究共收录了22篇文章和7篇摘要,涉及8088名患者。其中,3803 例接受了 CME,4285 例未接受 CME。分析结果表明,在三年无病生存率(DFS)和总生存率(OS)、局部复发、全身复发和总复发率以及住院时间方面,CME 更受青睐。不过,CME的血管损伤增加,手术时间延长。在三年生存率方面,仅在III期观察到CME的优越性。此外,在总体并发症、30天再入院率、再次手术率或术后死亡率方面,CME组和非CME组之间没有观察到明显差异:结论:应考虑对右侧结肠癌进行 CME 治疗,尤其是对 III 期患者,以改善肿瘤治疗效果。结论:应考虑对右侧结肠癌患者进行 CME 治疗,尤其是 III 期患者,这有助于改善肿瘤治疗效果,但必须注意血管损伤风险的增加。
{"title":"Complete mesocolic excision (CME) impacts survival only for Stage III right-sided colon cancer: a systematic review and meta-analysis.","authors":"Kengo Hayashi, Roberto Passera, Chiara Meroni, Rebecca Dallorto, Chiara Marafante, Carlo Alberto Ammirati, Alberto Arezzo","doi":"10.1080/13645706.2024.2405544","DOIUrl":"10.1080/13645706.2024.2405544","url":null,"abstract":"<p><strong>Introduction: </strong>Complete mesocolic excision (CME) is widely adopted for its assumed superior oncological outcome. However, it's unclear if all right-sided colon cancer patients benefit from CME. The aim of this systematic review is to investigate whether CME contributes to postoperative outcomes and to determine the surgical indications for CME.</p><p><strong>Material and methods: </strong>We searched eligible articles about CME versus non-CME procedures for right-sided colon cancer in the OVID Medline, Embase, and Cochrane CENTRAL databases, and a meta-analysis was conducted.</p><p><strong>Results: </strong>Twenty-two articles and seven abstracts involving 8088 patients were included in this study. Among them, 3803 underwent CME and 4285 non-CME procedures. The analysis showed that CME was favoured for three-year disease-free survival (DFS) and overall survival (OS), for local, systemic, and total recurrence, and for hospital stay durations. However, increased vascular injury and longer surgery time were observed in CME. Regarding the three-year OS, the superiority of CME was observed only in Stage III. Additionally, no significant differences were observed between CME and non-CME groups regarding overall complications, 30-day readmission rates, reoperation, or postoperative mortality rates.</p><p><strong>Conclusions: </strong>CME for right-sided colon cancer should be considered, particularly in Stage III patients, to contribute to improved oncological outcomes. However, careful attention must be paid to the increased risk of vascular injury.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"323-333"},"PeriodicalIF":1.7,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142349868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
vNOTES chromopertubation: a new method for assessing tubal patency and peritubal anatomy. 彩色插管:一种评估输卵管通畅和输卵管周围解剖的新方法。
IF 1.7 4区 医学 Q2 SURGERY Pub Date : 2024-12-01 DOI: 10.1080/13645706.2024.2435556
Murat Levent Dereli, Pınar Birol İlter, Esra Keleş, Gazi Yıldız, Pınar Yıldız, Özgür Kartal, Emre Mat

Background: We conducted a retrospective cohort study of women with suspected tubal factor infertility who underwent vaginal natural orifice endoluminal surgery (vNOTES) chromopertubation and adnexal anatomy assessment at a large referral hospital.

Methods: Twelve women aged between 29 and 38 years with suspected tubal factor infertility who underwent vNOTES chromopertubation were retrospectively examined. Demographic data, as well as clinical and surgical characteristics, were reviewed and the surgical technique was defined.

Results: The mean BMI was 34.2 ± 7.12 kg/m2 (range 24.7-42.6). No conversion to laparotomy or laparoscopy was required. The median operative time was 39 (26.5-42) minutes. The median VAS scores at six and 12 h postoperatively were 3.5 (3-4) and 2 (1-2), respectively. There were no complications and all patients were discharged at the 12th postoperative hour.

Conclusions: Considering the increased risk of surgical morbidity and mortality associated with increasing BMI and the difficulty in gaining access to the abdominal cavity not only in obese women but also in cases with previous extensive midline incisions, where dense intra-abdominal adhesions are likely, or in cases where esthetic considerations are important, vNOTES appears to be a useful alternative to assess tubal patency and adnexal anatomy and even to perform concomitant adnexal surgery.

背景:我们对在一家大型转诊医院接受阴道自然孔腔内手术(vNOTES)彩色插管和附件解剖评估的怀疑输卵管因素不孕的妇女进行了回顾性队列研究。方法:回顾性分析12例29 ~ 38岁怀疑输卵管因素不孕的妇女行vNOTES染色输卵管插管的资料。回顾了人口统计资料,以及临床和手术特征,并确定了手术技术。结果:平均BMI为34.2±7.12 kg/m2(范围24.7 ~ 42.6)。不需要转为剖腹手术或腹腔镜检查。中位手术时间为39(26.5-42)分钟。术后6 h和12 h VAS评分中位数分别为3.5(3-4)和2(1-2)。无并发症,术后12小时全部出院。结论:考虑到与BMI增加相关的手术发病率和死亡率增加的风险,以及肥胖妇女以及先前有广泛中线切口的病例难以进入腹腔,这些病例可能存在密集的腹内粘连,或者在需要考虑美学因素的情况下,vNOTES似乎是评估输卵管通畅和附件解剖甚至进行伴随附件手术的有用替代方法。
{"title":"vNOTES chromopertubation: a new method for assessing tubal patency and peritubal anatomy.","authors":"Murat Levent Dereli, Pınar Birol İlter, Esra Keleş, Gazi Yıldız, Pınar Yıldız, Özgür Kartal, Emre Mat","doi":"10.1080/13645706.2024.2435556","DOIUrl":"https://doi.org/10.1080/13645706.2024.2435556","url":null,"abstract":"<p><strong>Background: </strong>We conducted a retrospective cohort study of women with suspected tubal factor infertility who underwent vaginal natural orifice endoluminal surgery (vNOTES) chromopertubation and adnexal anatomy assessment at a large referral hospital.</p><p><strong>Methods: </strong>Twelve women aged between 29 and 38 years with suspected tubal factor infertility who underwent vNOTES chromopertubation were retrospectively examined. Demographic data, as well as clinical and surgical characteristics, were reviewed and the surgical technique was defined.</p><p><strong>Results: </strong>The mean BMI was 34.2 ± 7.12 kg/m<sup>2</sup> (range 24.7-42.6). No conversion to laparotomy or laparoscopy was required. The median operative time was 39 (26.5-42) minutes. The median VAS scores at six and 12 h postoperatively were 3.5 (3-4) and 2 (1-2), respectively. There were no complications and all patients were discharged at the 12th postoperative hour.</p><p><strong>Conclusions: </strong>Considering the increased risk of surgical morbidity and mortality associated with increasing BMI and the difficulty in gaining access to the abdominal cavity not only in obese women but also in cases with previous extensive midline incisions, where dense intra-abdominal adhesions are likely, or in cases where esthetic considerations are important, vNOTES appears to be a useful alternative to assess tubal patency and adnexal anatomy and even to perform concomitant adnexal surgery.</p>","PeriodicalId":18537,"journal":{"name":"Minimally Invasive Therapy & Allied Technologies","volume":" ","pages":"1-8"},"PeriodicalIF":1.7,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142770164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Minimally Invasive Therapy & Allied Technologies
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1